# OnCo record romiplostim (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/romiplostim/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "romiplostim" ;
  schema:name "Romiplostim"@en ;
  schema:alternateName "AMG 531"@en, "Nplate" ;
  schema:description "Romiplostim is a weekly injection that tells the bone marrow to make more platelets; it is approved for immune thrombocytopenia and for radiation injury, and is being tested for the low platelets that chemotherapy causes."@en ;
  schema:url <https://onco.cc/drugs/romiplostim/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Romiplostim> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=romiplostim>, <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125268> ;
  onco:status "established" ;
  onco:tag "gap-fill", "supportive-care" ;
  onco:modality "Thrombopoietin receptor agonist (peptibody), weekly injection" ;
  onco:approval "US 2008: Immune thrombocytopenia with insufficient response to corticosteroids, immunoglobulins or splenectomy" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/> ;
  onco:technologies <https://onco.cc/fronts/supportive-care/> ;
  onco:targets <https://onco.cc/targets/mpl/> ;
  onco:drugs <https://onco.cc/drugs/eltrombopag/> ;
  onco:companies <https://onco.cc/companies/amgen/> ;
  onco:terms <https://onco.cc/terms/thrombocytopenia/> ;
  onco:trials <https://onco.cc/trials/nct03937154/> .